🇺🇸 FDA

Intelligence Platform

Patents

Browse 13 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12383516

Albuterol aerosol suspension formulation for oral inhalation with high amount of green pro

Amphastar Pharmaceuticals, Inc. · Granted Tue Aug 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12370241

Nasal powder formulation for treatment of hypoglycemia

Amphastar Pharmaceuticals, Inc. · Granted Tue Jul 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12226456

Nasal powder formulation for treatment of hypoglycemia

Amphastar Pharmaceuticals, Inc. · Granted Tue Feb 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11938089

Medication delivery systems and methods

Amphastar Pharmaceuticals, Inc. · Granted Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11524987

Highly purified recombinant human insulin (RHI) API and methods of producing the same

Amphastar Pharmaceuticals, Inc. · Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11446360

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency meth

Amphastar Pharmaceuticals, Inc. · Granted Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10406210

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency meth

Amphastar Pharmaceuticals, Inc. · Granted Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10322168

High-purity inhalable particles of insulin and insulin analogues, and high-efficiency meth

Amphastar Pharmaceuticals, Inc. · Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258573

Micronized insulin and micronized insulin analogues prepared under acidic conditions, and

Amphastar Pharmaceuticals, Inc. · Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bi

Amphastar Pharmaceuticals, Inc. · Granted Tue Mar 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. · Granted Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468394

Sterile pharmaceutical composition and process for a solution of propofol emulsion having

Amphastar Pharmaceuticals, Inc. · Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6399087

Propofol formulation with enhanced microbial inhibition

Amphastar Pharmaceuticals, Inc. · Granted Tue Jun 04 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired